FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Golden State Medical Supply Losartan Potassium Recall

Losartan Potassium, 50 mg tablets, 90 count bottle

Golden State Medical Supply Inc. · Camarillo, CA

Risk level
Class II
Reported by FDA
Jul 17, 2019
Recall ID
D-1463-2019
Check your lot numberHow we source this data

Summary

Golden State Medical Supply recalled Losartan Potassium starting Jun 14, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1463-2019 on Jul 17, 2019. Reason: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products. Status: Terminated.

Why it was recalled

CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Product description

Losartan Potassium, 50 mg tablets, 90 count bottle, NDC 60429-317-90

Lot numbers, UPCs & expiration codes

Lot #: GS017651, Expiration 01/2020

Where it was sold

US Nationwide One (1) US government account. No foreign accounts.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1463-2019
Classification
Class II
Status
Terminated
Recall initiated
Jun 14, 2019
FDA report date
Jul 17, 2019
Quantity
14,955 bottles (1,345,950 tablets)
Recall type
Voluntary: Firm initiated
Recalling firm
Golden State Medical Supply Inc.

Original FDA data

Every field from FDA enforcement report D-1463-2019, exactly as published.

Show all FDA fields
City
Camarillo
State
CA
Status
Terminated
Country
United States
Event ID
83161
Address
5187 Camino Ruiz
Code information
Lot #: GS017651, Expiration 01/2020
Postal code
93012-8601
Report date
Jul 17, 2019
Product type
Drugs
Recall number
D-1463-2019
Classification
Class II
Recalling firm
Golden State Medical Supply Inc.
Product quantity
14,955 bottles (1,345,950 tablets)
Termination date
Feb 19, 2020
Reason for recall
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Losartan Potassium, 50 mg tablets, 90 count bottle, NDC 60429-317-90
Distribution pattern
US Nationwide One (1) US government account. No foreign accounts.
Recall initiation date
Jun 14, 2019
Center classification date
Jul 9, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1463-2019, published Jul 17, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls